Financial reports
10-Q
2024 Q3
Quarterly report
14 Mar 24
10-Q
2024 Q2
Quarterly report
13 Dec 23
10-Q
2024 Q1
Quarterly report
13 Sep 23
10-K
2023 FY
Annual report
24 Jul 23
10-Q
2023 Q3
Quarterly report
16 Mar 23
10-Q
2023 Q2
Quarterly report
13 Dec 22
10-Q
2023 Q1
Quarterly report
12 Sep 22
10-K
2022 FY
Annual report
22 Jul 22
10-Q
2022 Q3
Quarterly report
15 Mar 22
10-Q
2022 Q2
Quarterly report
13 Dec 21
Current reports
8-K
Champions Oncology Reports Quarterly Revenue of $12.0 Million
12 Mar 24
8-K
Champions Oncology Reports Quarterly Revenue of $11.6 Million
12 Dec 23
8-K
Submission of Matters to a Vote of Security Holders
19 Oct 23
8-K
Champions Oncology Announces the Addition of Brady Davis as President
17 Oct 23
8-K
Champions Oncology Reports Quarterly Revenue of $12.6 Million
13 Sep 23
8-K
Champions Oncology Reports Quarterly Revenue of $13.1 Million
24 Jul 23
8-K
Champions Oncology Announces $5M Stock Repurchase Program
5 Apr 23
8-K
Champions Oncology Reports Quarterly Revenue of $12.8 Million
15 Mar 23
8-K
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
13 Dec 22
8-K
Submission of Matters to a Vote of Security Holders
20 Oct 22
Registration and prospectus
424B4
Prospectus supplement with pricing info
10 Jun 16
S-1/A
IPO registration (amended)
24 May 16
S-1
IPO registration
26 Apr 16
424B3
Prospectus supplement
15 Oct 15
POS AM
Prospectus update (post-effective amendment)
25 Sep 15
8-A12B
Registration of securities on exchange
20 Aug 15
424B3
Prospectus supplement
19 May 15
S-1
IPO registration
11 May 15
D
$14M in equity / options, sold $14M, 11 investors
25 Mar 15
D
$2M in debt / options / securities to be acquired, sold $2M, 2 investors
12 Dec 14
Proxies
DEFA14A
Additional proxy soliciting materials
28 Aug 23
DEF 14A
Definitive proxy
28 Aug 23
DEF 14A
Definitive proxy
31 Aug 22
DEF 14A
Definitive proxy
29 Aug 22
DEFC14A
Proxy in contested solicitation
29 Aug 22
DEFA14A
Additional proxy soliciting materials
1 Sep 21
DEF 14A
Definitive proxy
30 Aug 21
DEFA14A
Additional proxy soliciting materials
11 Sep 20
DEFM14A
Proxy related to merger
10 Sep 20
DEF 14A
Definitive proxy
28 Aug 20
Other
EFFECT
Notice of effectiveness
9 Jun 16
CORRESP
Correspondence with SEC
8 Jun 16
CORRESP
Correspondence with SEC
8 Jun 16
CORRESP
Correspondence with SEC
23 May 16
UPLOAD
Letter from SEC
5 May 16
EFFECT
Notice of effectiveness
13 Oct 15
EFFECT
Notice of effectiveness
19 May 15
CORRESP
Correspondence with SEC
25 Mar 15
UPLOAD
Letter from SEC
25 Mar 15
UPLOAD
Letter from SEC
24 Mar 15
Ownership
4
Brady Davis
1 Apr 24
SC 13G
TOCQUEVILLE ASSET MANAGEMENT L.P.
12 Feb 24
4
Daniel Newman Mendelson
16 Jan 24
4
Daniel Newman Mendelson
12 Jan 24
4
Daniel Newman Mendelson
11 Jan 24
4
Daniel Newman Mendelson
10 Jan 24
4
Daniel Newman Mendelson
9 Jan 24
4
Daniel Newman Mendelson
8 Jan 24
4
Daniel Newman Mendelson
8 Jan 24
4
JOEL ACKERMAN
5 Jan 24